11-57542649-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001105565.3(SMTNL1):āc.7C>Gā(p.Gln3Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000623 in 1,604,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001105565.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMTNL1 | NM_001105565.3 | c.7C>G | p.Gln3Glu | missense_variant | 2/8 | ENST00000527972.6 | NP_001099035.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMTNL1 | ENST00000527972.6 | c.7C>G | p.Gln3Glu | missense_variant | 2/8 | 5 | NM_001105565.3 | ENSP00000432651.1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000142 AC: 34AN: 240128Hom.: 0 AF XY: 0.0000842 AC XY: 11AN XY: 130636
GnomAD4 exome AF: 0.0000606 AC: 88AN: 1452016Hom.: 0 Cov.: 32 AF XY: 0.0000540 AC XY: 39AN XY: 721580
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.7C>G (p.Q3E) alteration is located in exon 1 (coding exon 1) of the SMTNL1 gene. This alteration results from a C to G substitution at nucleotide position 7, causing the glutamine (Q) at amino acid position 3 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at